ReviewJournal of thoracic disease2026
Integrating interventional pulmonology and thoracic surgery: a multidisciplinary approach to advanced pulmonary care.
Review in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Recent advances in artificial intelligence across interventional pulmonology: a narrative review.Journal of thoracic disease · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over the past two decades, significant advances in minimally invasive diagnostics and therapeutics have catalyzed subspecialization in pulmonary and thoracic disciplines. Interventional pulmonology (IP) has expanded the bronchoscopic management of complex airway disease, emphysema, lung cancer, and pleural pathology, while thoracic surgery (TS) continues to provide definitive operative therapies. As the diagnostic and therapeutic boundaries between these fields overlap, a coordinated multidisciplinary team (MDT) structure is warranted to optimize patient selection, reduce delays to efficient care, and offer a reasonable escalation pathway from minimally invasive to surgical approaches. At Beth Israel Deaconess Medical Center, the Chest Disease Center integrates IP and TS within a unified divisional structure supported by joint clinics, shared referral pathways, and routine multidisciplinary conferences involving radiology, oncology, and other specialties as needed. In this descriptive review, we present an institutional blueprint for integrated care using four representative disease domains: expiratory central airway collapse (ECAC), emphysema requiring lung volume reduction (LVR) strategies, early-stage lung cancer and peripheral pulmonary nodules (PPNs), and pleural disease including complicated pleural infection (CPI) and persistent air leak (PAL). Amongst those clinical entities, early dual-specialty evaluation enables timely diagnosis, individualized treatment planning, and streamlined transitions between bronchoscopic and operative options. Additionally, this framework also facilitates clinical research integration, including prospective trials embedded within routine workflows. We propose that a unified IP-TS MDT model enhances coordination, preserves continuity, and improves the efficiency of complex pulmonary care delivery, offering a practical template for adoption by other institutions seeking to align procedural innovation with patient-centered outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.